RESMED INC Quarterly Deferred Tax Assets, Net of Valuation Allowance in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Resmed Inc quarterly Deferred Tax Assets, Net of Valuation Allowance history and growth rate from Q2 2010 to Q2 2024.
  • Resmed Inc Deferred Tax Assets, Net of Valuation Allowance for the quarter ending June 30, 2024 was $347M, a 27% increase year-over-year.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $347M +$73.8M +27% Jun 30, 2024 10-K 2024-08-09
Q2 2023 $274M +$65.6M +31.5% Jun 30, 2023 10-K 2024-08-09
Q2 2022 $208M +$10.2M +5.14% Jun 30, 2022 10-K 2023-08-11
Q2 2021 $198M +$58.3M +41.8% Jun 30, 2021 10-K 2022-08-12
Q2 2020 $139M +$2.41M +1.76% Jun 30, 2020 10-K 2021-08-17
Q2 2019 $137M +$60.3M +78.6% Jun 30, 2019 10-K 2020-08-13
Q2 2018 $76.7M -$7.96M -9.4% Jun 30, 2018 10-K 2019-08-08
Q2 2017 $84.7M +$6.37M +8.13% Jun 30, 2017 10-K 2018-08-17
Q2 2016 $78.3M +$27.3M +53.5% Jun 30, 2016 10-K 2017-08-04
Q2 2015 $51M +$127K +0.25% Jun 30, 2015 10-K 2016-08-05
Q2 2014 $50.9M -$8.83M -14.8% Jun 30, 2014 10-K 2015-08-07
Q2 2013 $59.7M +$10.5M +21.3% Jun 30, 2013 10-K 2014-08-08
Q2 2012 $49.2M +$7.78M +18.8% Jun 30, 2012 10-K 2013-08-13
Q2 2011 $41.5M +$3.65M +9.66% Jun 30, 2011 10-K 2012-08-14
Q2 2010 $37.8M Jun 30, 2010 10-K 2011-08-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.